HER2 Support Group Forums - VALANX Biotech secures ?3 million to advance LIV-1 ADC for metastatic triple-negative

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - VALANX Biotech secures ?3 million to advance LIV-1 ADC for metastatic triple-negative (https://her2support.org/vbulletin/showthread.php?t=71767)

News	03-12-2026 05:40 AM

VALANX Biotech secures ?3 million to advance LIV-1 ADC for metastatic triple-negative

VALANX Biotech (VALANX), a biotech company developing a technology for site-selectable, site-specific protein conjugation, today announced it has secured ?3 million to advance its lead antibody-drug conjugate (ADC) program.

More...

All times are GMT -7. The time now is 09:41 AM.